Neuren Pharmaceuticals
NEU.AX
#4834
Rank
โ‚น192.30 B
Marketcap
โ‚น1,517
Share price
-0.09%
Change (1 day)
38.68%
Change (1 year)

EPS for Neuren Pharmaceuticals (NEU.AX)

EPS in 2025: โ‚น14.95

According to Neuren Pharmaceuticals's latest financial reports the company's current EPS (TTM) is โ‚น14.95. In 2025 the company made an earnings per share (EPS) of โ‚น14.95 a decrease over its 2024 EPS that were of โ‚น65.04.

EPS history for Neuren Pharmaceuticals from 2002 to 2025

Annual EPS

Year EPS Change
2025โ‚น14.95-77.01%
2024โ‚น65.04-17.89%
2023โ‚น79.2182396.45%
2022โ‚น0.09601-102.13%
2021-โ‚น4.50-27.64%
2020-โ‚น6.22-12.55%
2019-โ‚น7.11-446.24%
2018โ‚น2.05-247.23%
2017-โ‚น1.40-85.3%
2016-โ‚น9.49-13.42%
2015-โ‚น10.9634.36%
2014-โ‚น8.16-47.14%
2013-โ‚น15.4483.64%
2012-โ‚น8.41-28.56%
2011-โ‚น11.77-46.5%
2010-โ‚น21.99-3690.16%
2009โ‚น0.61-100.76%
2008-โ‚น80.47-38.72%
2007-โ‚น131.3111.23%
2006-โ‚น118.0614.27%
2005-โ‚น103.32-42.59%
2004-โ‚น179.952.56%
2003-โ‚น175.4636.5%
2002-โ‚น128.54